BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus

Jo Ann Lindenfeld, Shakar F. Simon, Martin R. Zamora, Carlyne D. Cool, Eugene E. Wolfel, Brian D. Lowes, Nancy Ireland, Karin Keller, Rhonda Frisk, Linda Stepien, Joseph C. Cleveland, Ronald Zolty

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

While bronchiolitis obliterans organizing pneumonia (BOOP) has been associated with the use of sirolimus (SIR), the incidence in a consecutive group of patients given SIR to replace a calcineurin-inhibitor (CI) is unknown. Twenty-nine consecutive cardiac transplant recipients were switched from a CI to SIR to ameliorate CI-associated nephropathy or coronary graft atherosclerosis. Seven patients (24%) developed BOOP. The clinical characteristics and biopsy results of these patients are presented. The clinical course and response to withdrawal of SIR in all and steroids in four of seven patients suggested the diagnosis of BOOP. Chest X-rays and CT scans showed typical findings of BOOP in all seven patients. Infection was excluded in all patients. Biopsy results were characteristic of BOOP in six of seven patients. Six patients recovered and one died. BOOP is a common and potentially serious adverse event in cardiac transplant patients switched from a CI to SIR, especially when SIR is started late post-transplantation.

Original languageEnglish (US)
Pages (from-to)1392-1396
Number of pages5
JournalAmerican Journal of Transplantation
Volume5
Issue number6
DOIs
StatePublished - Jun 1 2005

Fingerprint

Cryptogenic Organizing Pneumonia
Sirolimus
Transplants
Biopsy
Transplant Recipients
Calcineurin Inhibitors
X Ray Computed Tomography
Coronary Artery Disease
Thorax
Transplantation
Steroids

Keywords

  • Bronchiolitis obliterans organizing pneumonia
  • Heart transplantation
  • Sirolimus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. / Lindenfeld, Jo Ann; Simon, Shakar F.; Zamora, Martin R.; Cool, Carlyne D.; Wolfel, Eugene E.; Lowes, Brian D.; Ireland, Nancy; Keller, Karin; Frisk, Rhonda; Stepien, Linda; Cleveland, Joseph C.; Zolty, Ronald.

In: American Journal of Transplantation, Vol. 5, No. 6, 01.06.2005, p. 1392-1396.

Research output: Contribution to journalArticle

Lindenfeld, JA, Simon, SF, Zamora, MR, Cool, CD, Wolfel, EE, Lowes, BD, Ireland, N, Keller, K, Frisk, R, Stepien, L, Cleveland, JC & Zolty, R 2005, 'BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus', American Journal of Transplantation, vol. 5, no. 6, pp. 1392-1396. https://doi.org/10.1111/j.1600-6143.2005.00849.x
Lindenfeld, Jo Ann ; Simon, Shakar F. ; Zamora, Martin R. ; Cool, Carlyne D. ; Wolfel, Eugene E. ; Lowes, Brian D. ; Ireland, Nancy ; Keller, Karin ; Frisk, Rhonda ; Stepien, Linda ; Cleveland, Joseph C. ; Zolty, Ronald. / BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. In: American Journal of Transplantation. 2005 ; Vol. 5, No. 6. pp. 1392-1396.
@article{421a93ee42774545ab82ed6cd841f9a1,
title = "BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus",
abstract = "While bronchiolitis obliterans organizing pneumonia (BOOP) has been associated with the use of sirolimus (SIR), the incidence in a consecutive group of patients given SIR to replace a calcineurin-inhibitor (CI) is unknown. Twenty-nine consecutive cardiac transplant recipients were switched from a CI to SIR to ameliorate CI-associated nephropathy or coronary graft atherosclerosis. Seven patients (24{\%}) developed BOOP. The clinical characteristics and biopsy results of these patients are presented. The clinical course and response to withdrawal of SIR in all and steroids in four of seven patients suggested the diagnosis of BOOP. Chest X-rays and CT scans showed typical findings of BOOP in all seven patients. Infection was excluded in all patients. Biopsy results were characteristic of BOOP in six of seven patients. Six patients recovered and one died. BOOP is a common and potentially serious adverse event in cardiac transplant patients switched from a CI to SIR, especially when SIR is started late post-transplantation.",
keywords = "Bronchiolitis obliterans organizing pneumonia, Heart transplantation, Sirolimus",
author = "Lindenfeld, {Jo Ann} and Simon, {Shakar F.} and Zamora, {Martin R.} and Cool, {Carlyne D.} and Wolfel, {Eugene E.} and Lowes, {Brian D.} and Nancy Ireland and Karin Keller and Rhonda Frisk and Linda Stepien and Cleveland, {Joseph C.} and Ronald Zolty",
year = "2005",
month = "6",
day = "1",
doi = "10.1111/j.1600-6143.2005.00849.x",
language = "English (US)",
volume = "5",
pages = "1392--1396",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus

AU - Lindenfeld, Jo Ann

AU - Simon, Shakar F.

AU - Zamora, Martin R.

AU - Cool, Carlyne D.

AU - Wolfel, Eugene E.

AU - Lowes, Brian D.

AU - Ireland, Nancy

AU - Keller, Karin

AU - Frisk, Rhonda

AU - Stepien, Linda

AU - Cleveland, Joseph C.

AU - Zolty, Ronald

PY - 2005/6/1

Y1 - 2005/6/1

N2 - While bronchiolitis obliterans organizing pneumonia (BOOP) has been associated with the use of sirolimus (SIR), the incidence in a consecutive group of patients given SIR to replace a calcineurin-inhibitor (CI) is unknown. Twenty-nine consecutive cardiac transplant recipients were switched from a CI to SIR to ameliorate CI-associated nephropathy or coronary graft atherosclerosis. Seven patients (24%) developed BOOP. The clinical characteristics and biopsy results of these patients are presented. The clinical course and response to withdrawal of SIR in all and steroids in four of seven patients suggested the diagnosis of BOOP. Chest X-rays and CT scans showed typical findings of BOOP in all seven patients. Infection was excluded in all patients. Biopsy results were characteristic of BOOP in six of seven patients. Six patients recovered and one died. BOOP is a common and potentially serious adverse event in cardiac transplant patients switched from a CI to SIR, especially when SIR is started late post-transplantation.

AB - While bronchiolitis obliterans organizing pneumonia (BOOP) has been associated with the use of sirolimus (SIR), the incidence in a consecutive group of patients given SIR to replace a calcineurin-inhibitor (CI) is unknown. Twenty-nine consecutive cardiac transplant recipients were switched from a CI to SIR to ameliorate CI-associated nephropathy or coronary graft atherosclerosis. Seven patients (24%) developed BOOP. The clinical characteristics and biopsy results of these patients are presented. The clinical course and response to withdrawal of SIR in all and steroids in four of seven patients suggested the diagnosis of BOOP. Chest X-rays and CT scans showed typical findings of BOOP in all seven patients. Infection was excluded in all patients. Biopsy results were characteristic of BOOP in six of seven patients. Six patients recovered and one died. BOOP is a common and potentially serious adverse event in cardiac transplant patients switched from a CI to SIR, especially when SIR is started late post-transplantation.

KW - Bronchiolitis obliterans organizing pneumonia

KW - Heart transplantation

KW - Sirolimus

UR - http://www.scopus.com/inward/record.url?scp=20544468144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544468144&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2005.00849.x

DO - 10.1111/j.1600-6143.2005.00849.x

M3 - Article

C2 - 15888046

AN - SCOPUS:20544468144

VL - 5

SP - 1392

EP - 1396

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 6

ER -